192 related articles for article (PubMed ID: 26850830)
1. Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions.
Kim HY; Kong S; Oh S; Yang J; Jo E; Ko Y; Kim SH; Hwang JY; Song R; Windisch MP
Antiviral Res; 2016 May; 129():39-46. PubMed ID: 26850830
[TBL] [Abstract][Full Text] [Related]
2. Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.
Mittapalli GK; Jackson A; Zhao F; Lee H; Chow S; McKelvy J; Wong-Staal F; Macdonald JE
Bioorg Med Chem Lett; 2011 Nov; 21(22):6852-5. PubMed ID: 21978675
[TBL] [Abstract][Full Text] [Related]
3. Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.
Lee M; Yang J; Park S; Jo E; Kim HY; Bae YS; Windisch MP
Antiviral Res; 2016 Aug; 132():287-95. PubMed ID: 27387825
[TBL] [Abstract][Full Text] [Related]
4. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
[TBL] [Abstract][Full Text] [Related]
5. A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.
Lee M; Yang J; Jo E; Lee JY; Kim HY; Bartenschlager R; Shin EC; Bae YS; Windisch MP
Sci Rep; 2017 Mar; 7():44676. PubMed ID: 28333153
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
[TBL] [Abstract][Full Text] [Related]
7. High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors.
He S; Jain P; Lin B; Ferrer M; Hu Z; Southall N; Hu X; Zheng W; Neuenswander B; Cho CH; Chen Y; Worlikar SA; Aubé J; Larock RC; Schoenen FJ; Marugan JJ; Liang TJ; Frankowski KJ
ACS Comb Sci; 2015 Oct; 17(10):641-52. PubMed ID: 26332742
[TBL] [Abstract][Full Text] [Related]
8. Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture.
Coburn GA; Fisch DN; Moorji SM; de Muys JM; Murga JD; Paul D; Provoncha KP; Rotshteyn Y; Han AQ; Qian D; Maddon PJ; Olson WC
PLoS One; 2012; 7(4):e35351. PubMed ID: 22545104
[TBL] [Abstract][Full Text] [Related]
9. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors.
Hwang JY; Kim HY; Park DS; Choi J; Baek SM; Kim K; Kim S; Seong S; Choi I; Lee HG; Windisch MP; Lee J
Bioorg Med Chem Lett; 2013 Dec; 23(23):6467-73. PubMed ID: 24125883
[TBL] [Abstract][Full Text] [Related]
10. Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle.
He S; Li K; Lin B; Hu Z; Xiao J; Hu X; Wang AQ; Xu X; Ferrer M; Southall N; Zheng W; Aubé J; Schoenen FJ; Marugan JJ; Liang TJ; Frankowski KJ
J Med Chem; 2017 Jul; 60(14):6364-6383. PubMed ID: 28636348
[TBL] [Abstract][Full Text] [Related]
11. A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound.
Madhvi A; Hingane S; Srivastav R; Joshi N; Subramani C; Muthumohan R; Khasa R; Varshney S; Kalia M; Vrati S; Surjit M; Ranjith-Kumar CT
Sci Rep; 2017 Jul; 7(1):5816. PubMed ID: 28725041
[TBL] [Abstract][Full Text] [Related]
12. Characterization and structure-activity relationship study of iminodipyridinopyrimidines as novel hepatitis C virus inhibitor.
Park DS; Jo E; Choi J; Lee M; Kim S; Kim HY; Nam J; Ahn S; Hwang JY; Windisch MP
Eur J Med Chem; 2017 Nov; 140():65-73. PubMed ID: 28923387
[TBL] [Abstract][Full Text] [Related]
13. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
[TBL] [Abstract][Full Text] [Related]
14. Methanolic Extract of
Hung TC; Jassey A; Lin CJ; Liu CH; Lin CC; Yen MH; Lin LT
Viruses; 2018 Nov; 10(12):. PubMed ID: 30486350
[TBL] [Abstract][Full Text] [Related]
15. Retinoid derivative Tp80 exhibits anti-hepatitis C virus activity through restoration of GI-GPx expression.
Nguyen BN; Okuno Y; Ajiro M; Iida K; Denawa M; Yamamoto M; Sakamoto N; Kagechika H; Hagiwara M
J Med Virol; 2017 Jul; 89(7):1224-1234. PubMed ID: 27922182
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action.
Windisch MP; Jo S; Kim HY; Kim SH; Kim K; Kong S; Jeong H; Ahn S; No Z; Hwang JY
Eur J Med Chem; 2014 May; 78():35-42. PubMed ID: 24675178
[TBL] [Abstract][Full Text] [Related]
17. Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.
Vausselin T; Séron K; Lavie M; Mesalam AA; Lemasson M; Belouzard S; Fénéant L; Danneels A; Rouillé Y; Cocquerel L; Foquet L; Rosenberg AR; Wychowski C; Meuleman P; Melnyk P; Dubuisson J
J Virol; 2016 Oct; 90(19):8422-34. PubMed ID: 27412600
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitors.
Hwang JY; Kim HY; Jo S; Park E; Choi J; Kong S; Park DS; Heo JM; Lee JS; Ko Y; Choi I; Cechetto J; Kim J; Lee J; No Z; Windisch MP
Eur J Med Chem; 2013; 70():315-25. PubMed ID: 24177358
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus in vitro replication is efficiently inhibited by acridone Fac4.
Campos GRF; Bittar C; Jardim ACG; Shimizu JF; Batista MN; Paganini ER; Assis LR; Bartlett C; Harris M; Bolzani VDS; Regasini LO; Rahal P
J Gen Virol; 2017 Jul; 98(7):1693-1701. PubMed ID: 28699869
[TBL] [Abstract][Full Text] [Related]
20. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
Calland N; Sahuc ME; Belouzard S; Pène V; Bonnafous P; Mesalam AA; Deloison G; Descamps V; Sahpaz S; Wychowski C; Lambert O; Brodin P; Duverlie G; Meuleman P; Rosenberg AR; Dubuisson J; Rouillé Y; Séron K
J Virol; 2015 Oct; 89(19):10053-63. PubMed ID: 26202241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
